About FDA
Percent of Office of In Vitro Diagnostics and Radiological Health (OIR) 510(k) decisions meeting MDUFA goals during the month
Dictionary: The Medical Device User Fee Amendments (MDUFA II) require FDA to pursue a comprehensive set of device review performance goals, intended to significantly improve the timeliness and predictability of FDA’s review of new devices. MDUFA II performance goals are measured by receipt cohort. By using the decision cohort, this measure provides a different approach to monitoring MDUFA related 510(k) performance goals. The measure tracks the number of 510(k) decisions made during the month that were within 90 FDA days. A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device (21 CFR 807.92(a)(3)) that is not subject to a Premarket Approval (PMA).
Submitters must compare their device to one or more similar legally marketed devices and make and support their substantial equivalency (SE) claims. A legally marketed device, as described in 21 CFR 807.92(a)(3), is a device that was legally marketed prior to May 28, 1976 (preamendments device), for which a PMA is not required, or a device which has been reclassified from Class III to Class II or I, or a device which has been found SE through the 510(k) process. The legally marketed device(s) to which equivalence is drawn is commonly known as the "predicate." Although devices recently cleared under 510(k) are often selected as the predicate to which equivalence is claimed, any legally marketed device may be used as a predicate.
Information is current as of December 31, 2012
Fiscal Year - 2013
| Time | Target | Percent |
|---|---|---|
| Oct 2012 | 90 | 100 |
| Nov 2012 | 90 | 88 |
| Dec 2012 | 90 | 97 |
| Jan 2013 | 90 | TBD |
| Feb 2013 | 90 | TBD |
| Mar 2013 | 90 | TBD |
| Apr 2013 | 90 | TBD |
| May 2013 | 90 | TBD |
| Jun 2013 | 90 | TBD |
| Jul 2013 | 90 | TBD |
| Aug 2013 | 90 | TBD |
| Sep 2013 | 90 | TBD |
FY 2013 YTD: 96%
Number of OIR 510(k) decisions made in 90 days or less during the month
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct 2012 | N/A | 45 |
| Nov 2012 | N/A | 38 |
| Dec 2012 | N/A | 69 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 152
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







